Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?

Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?

Trobaugh-Lotrario AD, Venkatramani R, Feusner JH.
PMID: 24608075

In this paper, we analyzed the cases with hepatoblastoma among 56 BWS patients. Patients with Beckwith-Wiedemann Syndrome (BWS) are 2,000 times more likely to get hepatoblastoma than the average population. At the time of diagnosis of hepatoblastoma, the mean age of the patients was 6 months. Of the 26 patients, 13 were born premature. Of 31 patients, 19 had hemihypertrophy and 32 of 33 had AFP levels at diagnosis. The overall survival rate was about 75%, of which 27 out of 36 survived. Of the 25 survivors, 24 received chemotherapy and surgery. All 9 patients who had undergone routine liver cancer screening were all alive until the time of the report, suggesting a prospective study of whether BWS patients will be regularly screened for further survival after early detection.

Popular posts from this blog

Mirels’ Classification for pathologic fractures

Tibial spine fracture

Adrena incidentaloma: Diagnosis & Treatments